Product Description: Scyllo-Inositol, an amyloid inhibitor, potentialy inhibits α-synuclein aggregation. Scyllo-Inositol stabilizes a non-fibrillar non-toxic form of amyloid-β peptide (Aβ42) in vitro, reverses cognitive deficits, and reduces synaptic toxicity and lowers amyloid plaques in an Alzheimer's disease mouse model[1].
Applications: Neuroscience-Neurodegeneration
Formula: C6H12O6
References: [1]Ibrahim T, et al. α-Synuclein aggregation, seeding and inhibition by scyllo-inositol. Biochem Biophys Res Commun. 2016 Jan 15;469(3):529-34.
CAS Number: 488-59-5
Molecular Weight: 180.16
Compound Purity: 98.0
Research Area: Neurological Disease
Solubility: H2O : 5 mg/mL (ultrasonic)
Target: Amyloid-β;Endogenous Metabolite